NCT02103114 - Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 27, 2016

Study Completion Date

July 1, 2016

Conditions

ATIII Deficiency

Interventions

DRUG

Anti-thrombin III

"Intraoperatively- (correcting to 100%) according to the following formula:~Units required = ((100%- baseline ATIII level\*%) X body weight)/1.4~* expressed as a % normal level based on functional ATIII assay"

OTHER

Placebo

Normal saline placebo

Trial Locations (1)

27708

Duke University, Durham